Critical Illness: Definition Failure, Survival Clause and the Moratorium
Mr Sunil Deshmukh, 55, has held a critical illness policy since 1 March 2019 with a sum insured of ₹25,00,000 covering 18 conditions, including "heart attack" and "coronary artery disease requiring surgery". The wording defines heart attack as death of heart muscle evidenced by typical chest pain plus fresh ECG changes plus a rise in cardiac markers - specifically troponin-I above 1.0 ng/mL - and states that "angioplasty, stent insertion or any other intra-arterial procedure is not covered under this condition". Coronary artery disease requiring surgery pays only where coronary artery bypass grafting is actually performed on at least three vessels with 60% or more stenosis. A 30-day survival period applies.
At proposal in 2019 he answered "No" to smoking. Hospital records from 2022, and the current admission record, document 20 pack-years.
On 3 July 2025 he was admitted with chest pain. Troponin-I peaked at 0.9 ng/mL; the ECG showed no ST elevation or fresh Q waves. Angiography found 70% stenosis in the LAD and 65% in the RCA; a single drug-eluting stent was placed on 5 July. He was discharged on 7 July and claimed ₹25,00,000.
1. Is the claim payable under either the heart attack or the coronary artery disease condition? Reason condition by condition.
Read the worked answer
Neither condition is satisfied.
Heart attack: the definition is conjunctive - all three limbs must be met. Chest pain is present, but the troponin-I peak of 0.9 ng/mL is below the stated threshold of 1.0 ng/mL, and the ECG shows no fresh ischaemic change. Two limbs fail, so the definition of the insured event is not met. The clinical reality that he had significant coronary disease and needed a stent does not convert the episode into a policy heart attack; critical illness policies insure defined severities, not diagnoses in general. The express carve-out that angioplasty and stent insertion are not covered under this condition reinforces the point.
Coronary artery disease requiring surgery: the clause requires bypass grafting actually performed, on at least three vessels with 60% or more stenosis. He had two diseased vessels and had angioplasty, not CABG. Not payable.
What the file should record is that the claim fails on the definition, not on disclosure - the two issues must be kept apart, because a denial on the wrong ground is what gets overturned in grievance redressal.
2. Can the insurer repudiate for the non-disclosure of smoking? Does the six-year history change the analysis?
Read the worked answer
No. The moratorium has run.
Critical illness cover is health insurance business, and the health framework bars an insurer from repudiating a policy on grounds of misrepresentation or non-disclosure after 60 months of continuous cover, save where fraud is established. The policy commenced on 1 March 2019 and the claim arose in July 2025 - roughly 76 months. The insurer is therefore confined to the policy's definitions and exclusions; it cannot reach back to the 2019 proposal.
Even inside the moratorium, the analysis would not be automatic. The insurer would need to show that the smoking history was material to its underwriting decision, that it would have declined or loaded the risk had it known, and that the suppression was not merely an immaterial inaccuracy; it must also follow due process with written reasons and a premium refund. Proven fraud is the only route around the moratorium, and fraud requires evidence of deliberate design, not merely an inaccurate answer later contradicted by hospital notes.
The practical consequence: the repudiation letter must rest squarely on the failure to meet the definitional thresholds, and the smoking history should stay on file as background only.
3. Suppose Mr Deshmukh had died on 23 July 2025, twenty days after diagnosis. How would the survival clause operate and what would you advise the claimant?
Read the worked answer
The survival period of 30 days would not have been satisfied, so the critical illness benefit of ₹25,00,000 would not become payable on the ordinary reading - and the definitional failure identified earlier means the claim would have failed anyway.
The clause is a condition precedent to the benefit, and its purpose is to keep the product to survivors of the defined event rather than to convert it into a death cover. Its enforceability depends on it being clearly disclosed and not buried: a survival condition printed in the policy schedule and explained in the prospectus is generally upheld, whereas one that appears only in an annexure and is contradicted by sales material invites a finding of unfair terms.
Advise the claimant to check three things before accepting a nil settlement. First, whether any death benefit, waiver-of-premium or return-of-premium provision operates - many critical illness contracts bundled with life cover pay the death benefit even where the illness benefit fails. Second, whether the claimant can show that the insured survived the qualifying period on the reckoning the contract intends, counting from diagnosis or from the date the definition was satisfied. Third, whether the survival clause was disclosed at the point of sale, which is the ground on which a grievance will be won if it was not.